Identification and Validation of Potential Biomarkers and Therapeutic Targets of COVID-19-related Depression
The identification of potential biomarkers represents a groundbreaking strategy for assessing and treating depression in the context of COVID-19, with the potential to reduce its prevalence among these patients. However, to fully harness this potential, additional clinical research is paramount.
Authors
- Qi Peng (ORCID: https://orcid.org/0000-0001-9487-2878)
- Mengjie Huang (ORCID: https://orcid.org/0000-0001-8163-8679)
- Haiyan Zhu (ORCID: https://orcid.org/0000-0002-0936-7656)
Institutions
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Combinatorial Chemistry & High Throughput Screening
- Published
- 2025-01-09
- DOI
- https://doi.org/10.2174/0113862073322931241030104813
- Primary Topic
- Bioinformatics and Genomic Networks
- Type
- article
- Field-Weighted Citation Impact
- 0.00